$10.13+4.65%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Immix Biopharma last closed at $10.13 (+4.65%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -16.2×. Its overall grade ranks 128 of 741 stocks in Healthcare.
About this company
Immix Biopharma last closed at $10.13 (+4.65%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A · 128/741
Valuation grade A+
Related stocks
- PfizerCompetitor
혈액암·종양 치료제 개발에서 대형 글로벌 경쟁사
- NovartisCompetitor
종양·희귀질환 치료제 개발 경쟁사
- Bristol Myers SquibbCompetitor
항암제 포트폴리오가 큰 글로벌 제약 경쟁사
About Immix Biopharma
- What technical signals does Immix Biopharma (IMMX) have?
- Immix Biopharma current technical signals: no active technical signal.
- Is Immix Biopharma a cup-and-handle pattern?
- No. Immix Biopharma has no valid Cup signal right now.
- What published figures are available for Immix Biopharma?
- Market cap: $528.31M. Trailing 12 months PER: -16.2×. Latest quarter PBR: 2.82×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Immix Biopharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy